Pyoderma gangrenosum and Sweet syndrome: the prototypic neutrophilic dermatoses

Pyoderma gangrenosum, a dramatic ulcerative skin disease, and Sweet syndrome, a papular dermatosis, were described independently. It was subsequently shown that they share many characteristics, including clinical overlap and the frequent association with multisystemic disorders. The group of the neutrophilic dermatoses encompasses these two dermatoses, as well as other conditions having in common an aseptic neutrophilic infiltrate predominating in the epidermis and/or the dermis and/or the subcutis. Some patients also experience neutrophilic infiltrates in other organs, defining the neutrophilic disease. Recent research suggests that the neutrophilic dermatoses could be considered as the cutaneous expression of the autoinflammation, an aberrant hyperproduction of interleukin‐1. Autoinflammation is responsible for monogenic diseases, and is also involved in the mechanism of many polygenic conditions, including the neutrophilic dermatoses.

[1]  P. Aronowitz,et al.  Drug-Induced Sweet‘s Syndrome , 2017, Journal of General Internal Medicine.

[2]  T. Petrella,et al.  Myelodysplasia Cutis Versus Leukemia Cutis. , 2015, The Journal of investigative dermatology.

[3]  S. Feldman,et al.  The genetics of pyoderma gangrenosum and implications for treatment: a systematic review , 2015, The British journal of dermatology.

[4]  M. Rybojad,et al.  Neutrophilic Skin Lesions in Autoimmune Connective Tissue Diseases , 2014, Medicine.

[5]  L. Schuchter,et al.  Ipilimumab-associated Sweet syndrome in a melanoma patient. , 2014, Journal of the American Academy of Dermatology.

[6]  D. Fanoni,et al.  Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet's syndrome , 2014, Clinical and experimental immunology.

[7]  Philip R. Cohen,et al.  Case of vemurafenib‐induced Sweet's syndrome , 2014, The Journal of dermatology.

[8]  Lawrence E Gibson,et al.  Histiocytoid Sweet syndrome may indicate leukemia cutis: a novel application of fluorescence in situ hybridization. , 2014, Journal of the American Academy of Dermatology.

[9]  E. Cowen,et al.  Autoinflammatory pustular neutrophilic diseases. , 2013, Dermatologic clinics.

[10]  W. Abramovits,et al.  Introduction to autoinflammatory syndromes and diseases. , 2013, Dermatologic clinics.

[11]  C. Ko,et al.  Neutrophilic dermatosis after azathioprine exposure. , 2013, JAMA dermatology.

[12]  H. Dombret,et al.  Evidence of differentiation in myeloid malignancies associated neutrophilic dermatosis: a fluorescent in situ hybridization study of 14 patients. , 2013, The Journal of investigative dermatology.

[13]  S. Langan,et al.  Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study. , 2012, The Journal of investigative dermatology.

[14]  S. Edmonds,et al.  Sweet’s syndrome after adalimumab therapy for refractory relapsing polychondritis , 2011, BMJ Case Reports.

[15]  T. Glant,et al.  Mutations in the PSTPIP1 gene and aberrant splicing variants in patients with pyoderma gangrenosum , 2011, Clinical and experimental dermatology.

[16]  A. Qureshi,et al.  Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients , 2011, The British journal of dermatology.

[17]  K. Danno,et al.  A Case of Acne Fulminans in a Patient with Ulcerative Colitis Successfully Treated with Prednisolone and Diaminodiphenylsulfone: A Literature Review of Acne Fulminans, Rosacea Fulminans and Neutrophilic Dermatoses Occurring in the Setting of Inflammatory Bowel Disease , 2011, Dermatology.

[18]  Sewon Kang,et al.  Alteration in the gene encoding protein tyrosine phosphatase nonreceptor type 6 (PTPN6/SHP1) may contribute to neutrophilic dermatoses. , 2011, The American journal of pathology.

[19]  R. Panush An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist , 2011 .

[20]  S. Feldman,et al.  Pyoderma gangrenosum: a review and update on new therapies. , 2010, Journal of the American Academy of Dermatology.

[21]  R. Anadolu,et al.  Sweet’s syndrome in familial Mediterranean fever: possible continuum of the neutrophilic reaction as a new cutaneous feature of FMF , 2009, Journal of cutaneous pathology.

[22]  D. Lipsker,et al.  Neutrophilic Urticarial Dermatosis: A Variant of Neutrophilic Urticaria Strongly Associated With Systemic Disease. Report of 9 New Cases and Review of the Literature , 2009, Medicine.

[23]  Kory H Kitagawa,et al.  Primary pyoderma gangrenosum of the lungs. , 2008, Journal of the American Academy of Dermatology.

[24]  C. Magro,et al.  Clonality in the setting of Sweet’s syndrome and pyoderma gangrenosum is not limited to underlying myeloproliferative disease , 2007, Journal of cutaneous pathology.

[25]  B. Sriha,et al.  Aggravation à type de syndrome de Sweet d'une acné traitée par isotrétinoïne , 2007 .

[26]  C. Belajouza,et al.  [Sweet's syndrome complicating isotretinoin therapy in acne]. , 2007, Annales de dermatologie et de venereologie.

[27]  M. Vignon-Pennamen,et al.  From acute febrile neutrophilic dermatosis to neutrophilic disease: forty years of clinical research. , 2006, Journal of the American Academy of Dermatology.

[28]  H. Kutzner,et al.  Histiocytoid Sweet syndrome: a dermal infiltration of immature neutrophilic granulocytes. , 2005, Archives of dermatology.

[29]  R. Weenig,et al.  Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria , 2004, International journal of dermatology.

[30]  H. H. Wolff,et al.  Erythema elevatum diutinum , 1978, Archives of Dermatological Research.

[31]  P. R. Dahl,et al.  Skin ulcers misdiagnosed as pyoderma gangrenosum. , 2002, The New England journal of medicine.

[32]  M. Vignon-Pennamen The extracutaneous involvement in the neutrophilic dermatoses. , 2000, Clinics in dermatology.

[33]  J. Reed,et al.  Subcorneal pustular dermatosis. , 2000, Clinics in dermatology.

[34]  Philip R. Cohen,et al.  Sweet's syndrome: a neutrophilic dermatosis classically associated with acute onset and fever. , 2000, Clinics in dermatology.

[35]  Domingo,et al.  Pyoderma gangrenosum with liver, spleen and btone involvement in a patient with chronic myelomonocytic leukaemia , 1999, The British journal of dermatology.

[36]  Philip R. Cohen,et al.  Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet's syndrome. , 1996, Journal of the American Academy of Dermatology.

[37]  W. Su,et al.  Pyoderma gangrenosum: classification and management. , 1996, Journal of the American Academy of Dermatology.

[38]  E. Berti,et al.  Amicrobial pustular dermatosis of cutaneous folds associated with autoimmune disorders: a new entity? , 1996, Dermatology.

[39]  J. Boss,et al.  Acute neutrophilic myositis in Sweet's syndrome: late phase transformation into fibrosing myositis and panniculitis. , 1995, Human pathology.

[40]  G. Koester,et al.  Bullous pyoderma gangrenosum. , 1993, Journal of the American Academy of Dermatology.

[41]  A. Hastings,et al.  Sweet's syndrome progressing to pyoderma gangrenosum—a spectrum of neutrophilic skin disease in association with cryptogenic cirrhosis , 1991, Clinical and experimental dermatology.

[42]  M. Vignon-Pennamen,et al.  Cutaneous Manifestations of Neutrophilic Disease , 1991 .

[43]  D. Wallach LES DERMATOSES NEUTROPHILIQUES , 1991 .

[44]  H. Mensing,et al.  Acute febrile neutrophilic dermatosis (Sweet's syndrome) caused by minocycline. , 1991, Dermatologica.

[45]  D. S. Santa Cruz,et al.  Neutrophilic dermatoses. , 1989, Seminars in dermatology.

[46]  R. Winkelmann,et al.  Superficial granulomatous pyoderma: a localized vegetative form of pyoderma gangrenosum. , 1988, Journal of the American Academy of Dermatology.

[47]  E. Benton,et al.  Sweet's syndrome and pyoderma gangrenosum associated with ulcerative colitis. , 1985, Acta dermato-venereologica.

[48]  H. Haynes,et al.  Neutrophilic dermatosis of myeloproliferative disorders. Atypical forms of pyoderma gangrenosum and Sweet's syndrome associated with myeloproliferative disorders. , 1983, Journal of the American Academy of Dermatology.

[49]  K. Holbrook,et al.  Fatal cardiovascular disease and cutis laxa following acute febrile neutrophilic dermatosis. , 1983, The Journal of pediatrics.

[50]  M. Mihm,et al.  Neutrophilic Eccrine Hidradenitis: A Distinctive Type of Neutrophilic Dermatosis Associated With Myelogenous Leukemia and Chemotherapy , 1982 .

[51]  J. Burton Sweet's syndrome, pyoderma gangrenosum and acute leukaemia , 1980, The British journal of dermatology.

[52]  H. Perry,et al.  A diffuse pustular eruption associated with ulcerative colitis. , 1978, Archives of dermatology.

[53]  R. Pye,et al.  Bullous pyoderma as a presentation of acute leukaemia , 1977, Clinical and experimental dermatology.

[54]  R. Winkelmann,et al.  Bullous pyoderma gangrenosum and leukemia. , 1972, Archives of dermatology.

[55]  R. Sweet AN ACUTE FEBRILE NEUTROPHTLIC DERMATOSTS. , 1964 .

[56]  R. Sweet AN ACUTE FEBRILE NEUTROPHILIC DERMATOSIS. , 1964, The British journal of dermatology.

[57]  G PLACITELLI,et al.  [Ulcerative colitis]. , 1958, La Riforma medica.

[58]  O. Cañizares,et al.  Cutaneous manifestations of myelogenous leukemia. , 1955, A.M.A. archives of dermatology.

[59]  F. Meleney,et al.  PROGRESSIVE GANGRENOUS INFECTION OF THE SKIN AND SUBCUTANEOUS TISSUES, FOLLOWING OPERATION FOR ACUTE PERFORATIVE APPENDICITIS: A STUDY IN SYMBIOSIS. , 2022, Annals of surgery.